FTH compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

FTHFaeth Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

FTHFaeth Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

FTHFaeth Therapeutics, Inc.

19.60▼−0.24%

Mkt cap$507.8MRevenue—Revenue—

LLYELI Lilly & Co

1,430.07▲+1.47%

Regular sessionNov 4 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 4 '26

FTHFaeth Therapeutics, Inc.

LLYELI Lilly & Co

19.60▼−0.24%

Price

1,430.07▲+1.47%

$507.8M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

FTH19.60▼−0.24%vsLLY1,430.07▲+1.47%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

FTH: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only FTH 2

TAKTakeda Pharmaceuticalsupplier

—The Regents of the University of Californiaunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

FTH, solidLLY, dashed